A detailed history of Belpointe Asset Management LLC transactions in Incyte Corp stock. As of the latest transaction made, Belpointe Asset Management LLC holds 3,595 shares of INCY stock, worth $212,176. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,595
Previous 3,390 6.05%
Holding current value
$212,176
Previous $212,000 3.77%
% of portfolio
0.02%
Previous 0.02%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$56.55 - $66.59 $11,592 - $13,650
205 Added 6.05%
3,595 $204,000
Q4 2023

Feb 13, 2024

BUY
$52.16 - $64.19 $176,822 - $217,604
3,390 New
3,390 $212,000
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $159,281 - $195,070
2,268 Added 5968.42%
2,306 $166,000
Q4 2022

Feb 08, 2023

BUY
$67.18 - $84.11 $2,552 - $3,196
38 New
38 $3,000
Q3 2020

Nov 13, 2020

BUY
$85.07 - $109.69 $396,000 - $510,606
4,655 New
4,655 $341,000
Q2 2020

Jul 20, 2020

SELL
$74.18 - $108.93 $345,307 - $507,069
-4,655 Closed
0 $0
Q1 2020

Jul 20, 2020

BUY
$63.18 - $85.97 $294,102 - $400,190
4,655 New
4,655 $341,000
Q4 2019

Feb 18, 2020

SELL
$73.04 - $95.72 $400,551 - $524,928
-5,484 Closed
0 $0
Q3 2019

Jan 16, 2020

BUY
$72.82 - $86.52 $399,344 - $474,475
5,484 New
5,484 $407,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $13.1B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.